US Stock MarketDetailed Quotes
VRNA Verona Pharma
- 37.860
- -0.990-2.55%
Close Nov 21 16:00 ET
- 37.650
- -0.210-0.55%
Post 19:59 ET
3.10BMarket Cap-18930P/E (TTM)
39.575High37.860Low815.12KVolume39.380Open38.850Pre Close31.40MTurnover10.49%Turnover RatioLossP/E (Static)81.83MShares40.12952wk High23.74P/B294.16MFloat Cap11.39052wk Low--Dividend TTM7.77MShs Float40.129Historical High--Div YieldTTM4.41%Amplitude2.010Historical Low38.523Avg Price1Lot Size
Verona Pharma Key Stats
Quarterly+Annual
YOY
| (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | -392.30%-62.66M | 19.75%-17.1M | -135.39%-13.61M | 16.10%-50.22M | -34.43%-10.4M | 29.67%-12.73M | -9.19%-21.31M | 60.16%-5.78M | -80.01%-59.86M | 55.33%-7.74M |
| Net income from continuing operations | -192.52%-42.96M | -704.30%-70.84M | -54.06%-25.79M | 20.86%-54.37M | -35.22%-14.13M | 6.14%-14.69M | 50.43%-8.81M | 32.59%-16.74M | -23.63%-68.7M | 55.07%-10.45M |
| Operating gains losses | -245.75%-1.48M | 590.27%3.63M | 123.50%219K | -140.28%-1.87M | 51.23%-1.21M | -73.71%1.01M | -134.63%-740K | -183.29%-932K | 126.59%4.63M | 84.28%-2.47M |
| Depreciation and amortization | 71.61%266K | 71.97%270K | 67.52%263K | 6.45%677K | 37.75%208K | -1.27%155K | -4.85%157K | -3.68%157K | 1.11%636K | -6.79%151K |
| Other non cash items | 12,406.25%6M | 385.42%233K | 89.01%172K | 18.09%222K | 29.63%35K | -11.11%48K | -9.43%48K | 68.52%91K | -21.34%188K | -49.06%27K |
| Change In working capital | -641.60%-32.14M | 299.54%34.01M | -1.13%7.27M | -29.43%-13.9M | -75.40%124K | 53.52%-4.33M | -138.06%-17.04M | 40.34%7.36M | -179.87%-10.74M | -97.08%504K |
| -Change in receivables | -2,846.77%-8.52M | 302.79%7.79M | 74.71%-585K | -127.85%-1.1M | -107.91%-1.03M | 111.69%310K | 139.59%1.93M | -46.58%-2.31M | 157.25%3.96M | 21.61%13.08M |
| -Change in prepaid assets | -3.81%-2.53M | -371.51%-1.81M | -100.53%-5K | -172.69%-1.12M | -133.29%-285K | -277.18%-2.44M | 119.14%667K | -66.39%938K | 206.99%1.54M | -67.51%856K |
| -Change in payables and accrued expense | 440.34%5.97M | 145.87%7.37M | -19.57%6.77M | 29.73%-10.9M | 89.49%-1.51M | 74.98%-1.76M | -1,557.35%-16.06M | 78.03%8.42M | -172.49%-15.51M | -359.40%-14.33M |
| -Change in other current assets | -255.33%-867K | 73.15%-907K | -30.84%942K | 158.64%777K | 7,492.50%3.04M | 80.03%-244K | -1,158.93%-3.38M | 394.81%1.36M | -69.22%-1.33M | 103.95%40K |
| -Change in other current liabilities | -10,472.95%-21.89M | 10,623.41%21.57M | 114.18%149K | -358.93%-1.55M | -110.20%-88K | -210.70%-207K | 3.30%-205K | -339.75%-1.05M | 179.65%599K | 237.20%863K |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | -392.30%-62.66M | 19.75%-17.1M | -135.39%-13.61M | 16.10%-50.22M | -34.43%-10.4M | 29.67%-12.73M | -9.19%-21.31M | 60.16%-5.78M | -80.01%-59.86M | 55.33%-7.74M |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | 0 | -29K | -16K | 0 | 0 | 0 | 0 | 0 | -141.67%-29K | 0 |
| Net PPE purchase and sale | --0 | ---29K | ---16K | --0 | --0 | --0 | --0 | --0 | -141.67%-29K | --0 |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | --0 | ---29K | ---16K | --0 | --0 | --0 | --0 | --0 | -141.67%-29K | --0 |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | -14,864.58%-7.09M | 134,441.94%166.83M | -104.55%-3.12M | -34.05%92.87M | 818.59%24.01M | -99.97%48K | 118.00%124K | 9,560.74%68.69M | 2,402.08%140.82M | 390.12%2.61M |
| Net issuance payments of debt | --100M | --70.24M | --0 | 674.16%38.71M | 474.24%28.71M | --0 | --0 | --10M | --5M | --5M |
| Net common stock issuance | --0 | --0 | --0 | -62.01%56.91M | --0 | --0 | --47K | 84,768.66%56.86M | 20,336.15%149.8M | --0 |
| Proceeds from stock option exercised by employees | 7,541.67%3.67M | --0 | -55.34%816K | 42.06%1.95M | -100.30%-3K | -87.06%48K | --77K | --1.83M | --1.37M | --1M |
| Net other financing activities | ---110.76M | --96.59M | ---3.94M | 69.40%-4.7M | ---- | ---- | ---- | ---- | -124.10%-15.35M | -275.92%-3.39M |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | -14,864.58%-7.09M | 134,441.94%166.83M | -104.55%-3.12M | -34.05%92.87M | 818.59%24.01M | -99.97%48K | 118.00%124K | 9,560.74%68.69M | 2,402.08%140.82M | 390.12%2.61M |
| Net cash flow | ||||||||||
| Beginning cash position | 49.45%404.6M | -12.54%254.88M | 19.29%271.77M | 53.54%227.83M | 11.08%257.37M | 142.78%270.73M | 119.50%291.42M | 53.54%227.83M | -21.07%148.38M | 39.12%231.7M |
| Current changes in cash | -450.06%-69.74M | 806.57%149.7M | -126.63%-16.75M | -47.30%42.65M | 365.61%13.61M | -110.43%-12.68M | -4.70%-21.19M | 512.80%62.9M | 305.49%80.93M | 71.88%-5.12M |
| Effect of exchange rate changes | 273.46%1.18M | -96.79%16K | -120.58%-141K | 187.70%1.3M | -36.32%796K | 48.84%-682K | 148.97%499K | 281.22%685K | -563.68%-1.48M | 2,055.17%1.25M |
| End cash Position | 30.57%336.04M | 49.45%404.6M | -12.54%254.88M | 19.29%271.77M | 19.29%271.77M | 11.08%257.37M | 142.78%270.73M | 119.50%291.42M | 53.54%227.83M | 53.54%227.83M |
| Free cash flow | -392.30%-62.66M | 19.61%-17.13M | -135.66%-13.63M | 16.14%-50.22M | -34.43%-10.4M | 29.67%-12.73M | -9.03%-21.31M | 60.16%-5.78M | -80.04%-59.89M | 55.33%-7.74M |
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data